Stay updated on Adagrasib + BI 1701963 in Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.

Latest updates to the Adagrasib + BI 1701963 in Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedUpdated the displayed ClinicalTrials.gov interface revision label from v3.5.2 to v3.5.3. This represents a site/versioning change rather than a change to the study record itself.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedA new Record History revision v3.5.0 was added. Revision v3.4.3 was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry v3.4.3 was added to the record history and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.4.2 has been added to the Study Record Versions, and the funding-lapse notice along with the v3.4.1 revision entry have been removed.SummaryDifference0.8%

- Check95 days agoChange DetectedA site-wide notice about government funding and a new site version (v3.4.1) were added, while the previous version tag (v3.4.0) was removed. These updates do not affect the study record details or history.SummaryDifference0.8%

Stay in the know with updates to Adagrasib + BI 1701963 in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + BI 1701963 in Cancer Clinical Trial page.